Tenascin-C as a potential biomarker and therapeutic target for esophageal squamous cell carcinoma
Yang Liu(Hebei General Hospital), Ming‐Rong Wang(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 4
Related Papers
ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis
|Journal of Experimental & Clinical Cancer Research|2018|165
Circulating tumor DNA detection in lung cancer patients before and after surgery
|Scientific Reports|2016|121
The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming
|Journal of Experimental & Clinical Cancer Research|2019|81
Single-cell and spatial transcriptome analyses reveal tertiary lymphoid structures linked to tumour progression and immunotherapy response in nasopharyngeal carcinoma
|Nature Communications|2024|72
MCMs expression in lung cancer: implication of prognostic significance
|Journal of Cancer|2017|63